Sign in
4

Changes in Ownership

MIRA PHARMACEUTICALS, INC. Filed Acc 0001493152-26-014697

Options or other derivatives

  • Chief Executive Officer acquired 83,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Aminov Erez Chief Executive Officer 2026-03-30 Grant or award · Restricted Stock Units +83,500 83,500 D: show line 1 in the form
Loading xslF345X06/ownership.xml…